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Almost all forms of periodontal disease occur as a result
of mixed microbial infections. However, intensive studies
have suggested a prime pathogenic role for Porphyro-
monas gingivalis (a gram-negative anaerobic bacterium)
and its constituent lipopolysaccharide (LPS) that is
present on the P. gingivalis outer membrane (reviewed in
Ref. 1). The pathogenic action of P. gingivalis LPS
leading to periodontal tissue destruction is unclear,
possibly because its action is multifactorial and aﬀects
many cell types present within the periodontium. Several
studies have demonstrated that P. gingivalis LPS pro-
motes the expression of pro-inﬂammatory cytokines and
chemokines in monocytes and macrophages (2), den-
dritic cells (3), and the resident gingival connective tissue
ﬁbroblasts (4). Pertinent to inﬂammatory alveolar bone
destruction, P. gingivalis LPS also increases the release
of inﬂammatory osteolytic factors from osteoblastic cells
to stimulate, indirectly and directly, osteoclastic bone
resorption (5–9).
The pathology of inﬂammatory periodontal disease
progresses through cycles of tissue destruction, followed
by periods of quiescence and tissue repair. The severity
of tissue damage may therefore be considered to be
directly proportional to the induction of the host im-
muno-inﬂammatory response and the inability of the
periodontal tissues to undergo repair. During wound
healing, bone tissue repair is facilitated by the recruit-
ment of progenitor cells that are present in the peri-
odontal ligament adjacent to the alveolar bone and the
bone marrow space. A cocktail of growth factors, such as
bone morphogenic proteins (BMP), transforming growth
factor-b (TGF-b), and platelet derived growth factor
(PDGF), which are released as part of the repair process,
stimulate the proliferation and diﬀerentiation of the
progenitor cells to form osteoblasts that are capable of
the eventual synthesis of a mineralized matrix (10, 11).
In the repair process, the structural proteins of the
extracellular matrix play major roles in the formation of
a functional tissue. Important proteins in this process are
the proteoglycans decorin and biglycan, which are
characterized by a common 45–50 kDa leucine-rich
repeat core protein, the N-terminal of which is conju-
gated to one and two glycosaminoglycan (GAG) chains,
respectively (12, 13). Both decorin and biglycan are
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present in signiﬁcant amounts in mineralized tissues,
where the GAG chains are predominantly chondroitin
sulfate (CS) (14, 15). By contrast, in non-mineralized
connective tissues, such as skin, ligament and tendon,
dermatan sulfate (DS) GAG chains predominate (16),
although such forms of decorin and biglycan have also
recently been found in the premineralized tissues of
osteoid and predentine (17, 18). Through their diﬀeren-
tial expression during osteogenesis (17) and their varied
aﬃnities with matrix components, decorin and biglycan
exert diﬀerent eﬀects on collagen ﬁbrillogenesis (19–22),
on the presentation of growth factors, such as TGF-b
(23, 24) and tumor necrosis factor-a (TNF-a) (25), and in
the regulation of hydroxyapatite crystal growth and
morphogenesis (22, 26, 27). It is being increasingly rec-
ognized that the tempero-spatial expression of the vari-
ous structural and signalling components during bone
remodelling is not only important in determining tissue
repair leading to healthy tissue regeneration, but is crit-
ical in the matrixs inﬂuence of events associated with
tissue damage (10).
Although the inﬂuence of LPS on osteoclasts and bone
resorption has been studied extensively (9, 28–30), the
underlying eﬀects of P. gingivalis LPS on osteoblasts and
the bone repair process are less well deﬁned. Some
studies have indicated that P. gingivalis LPS and soni-
cated bacterial extracts inhibit various osteogenic
parameters, such as alkaline phosphatase activity, col-
lagen synthesis and bone nodule formation, implying
that periodontal pathogens inhibit bone formation (5,
31–33). A limited number of studies have further inves-
tigated the eﬀects of P. gingivalis LPS on the production
of extracellular matrix protein associated with bone
formation. Kadono et al. (33) demonstrated that
P. gingivalis LPS inhibited the production of osteocalcin
and osteopontin in rat calvaria cells. However, the
inﬂuence of P. gingivalis LPS on other matrix proteins is
poorly understood.
The present study aimed to investigate the eﬀects of
P. gingivalis LPS extract on osteoblastic proliferation
and phenotypic development leading to the synthesis of a
mineralized matrix, using a novel in vitro alveolar bone
culture system. The use of primary osteoblasts, derived
from alveolar bone, provides a signiﬁcant model culture
system that is highly representative for the study of
inﬂammatory periodontal disease. Past studies have
indicated that alveolar bone, compared with other osse-
ous sites, has a high metabolic turnover rate, has com-
positional diﬀerences within the extracellular matrix, and
is strongly inﬂuenced by the cellular activity of the
periodontal ligament in contributing progenitor cells (15,
34–36), which may reﬂect its increased susceptibility to
periodontal disease.
Material and methods
Isolation and culture of alveolar bone cells
Alveolar bone immediately surrounding incisor and molar
teeth was dissected from 28-d-old male Wistar rats.
Bone fragments were cleared of periodontal ligament by
treatment with 1 mg ml)1 of type IV collagenase/4.5 U ml)1
of type IV elastase (Sigma-Aldrich, Gillingham, UK) for 2 h
at 37C and then washed several times with sterile phos-
phate-buﬀered saline (PBS). The bone fragments were cul-
tured in RPMI-1640 and F-12 HAMS (1:1) containing 10%
fetal bovine serum (heat inactivated) (Invitrogen, Paisley,
UK), 5 mg ml)1 of transferrin-sodium-selenite (Sigma-
Aldrich), and antibiotics (10,000 units ml)1 of penicillin G,
10 mg ml)1 of streptomycin, and 25 mg ml)1 of amphoter-
icin B) (Invitrogen), at 37C in an atmosphere of 5% CO2.
Initial cell migration from the bone fragments appeared at
5–7 d, with conﬂuency around 3–5 wk, after which cells
were reseeded at 1 · 104 cells cm)2 and cultured in the
above medium. After 5 d in culture, the cells were supple-
mented with 50 lg ml)1 of ascorbic acid, 10 mM b-glyc-
erophosphate, 10)8 M dexamethasone, and 1 mM CaCl2
(Sigma-Aldrich). In developing this protocol, various types
of culture media were investigated to identify the optimal
growth conditions. Of note, cells incubated in the presence
of mineral-inducing factors, 10 mM b-glycerophosphate,
10)8 M dexamethasone, and 50 lg ml)1 ascorbic acid, from
the onset of culture, maintained poor cell viability and thus
failed to develop an osteoblastic phenotype or to produce
mineralizing bone nodules.
Phases relating to cell growth, matrix synthesis, and
mineral deposition were determined for the duration of the
culture. Viable cell counts were determined every 24 h
during 1–5 d of culture, by staining with 0.5 mg ml)1 of
ethidium bromide/0.15 mg ml)1 of acridine orange and
viewing immediately under a ﬂuorescence microscope.
Matrix synthesis was monitored over 5–28 d of culture.
Cells were ﬁxed with 2% formaldehyde for 30 min and then
blocked with normal horse serum (Sigma-Aldrich) for
10 min. Cells were incubated for 1 h with rabbit monoclonal
anti-human collagen type I (Biodesign International, Saco,
ME, USA; 1:10), rabbit polyclonal to anti-rat osteocalcin
(Cambio, Cambridge UK; 1:50), anti-human osteopontin
(LF123; 1:50), anti-mouse osteonectin (LF-23; 1:50), or
human bone sialoprotein (LF28; 1:50) (LF antibodies from
Dr L. Fisher, NIH, Bethesda, MD, USA). All antibodies
used had previously been reported to exhibit cross-reactivity
with rat tissues. Immunoreactivity was detected using the
universal peroxidase Vectastain (Vector Laboratories, Bur-
lingame, CA, USA). Negative controls included the omis-
sion of primary antibodies. The presence of calcium
phosphate mineral deposition was determined by von Kossa
staining (37).
Preparation of Porphomonas gingivalis LPS
Porphomonas gingivalis W50 was cultured anaerobically in
fastidious anaerobic broth (Lab M, Bury, UK) for 72 h,
37C. Lipopolysaccharide was extracted from bacterial cells
using the hot phenol–water method described by Westphal
& Jann (38). Brieﬂy, pelleted bacterial cells were suspended
in equal volumes of 90% phenol and double-distilled water,
shaken vigorously for 20 min at 65–68C, and immediately
cooled in an ice bath. Following centrifugation at 8,000 g
for 20 min, the upper aqueous layer, containing the crude
LPS, was collected. The remaining insoluble and phenol
layers were re-extracted further with double-distilled water
and pooled with the above collected aqueous extract.
Aqueous extracts were exhaustively dialysed against double-
distilled water and then lyophilized. The extract was treated
with 2% cetyltrimethylammonium bromide (Sigma-Aldrich)
for 15 min at room temperature to precipitate nucleic acids,
centrifuged at 3,000 g for 20 min, and the collected super-
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natant was then lyophilized. To remove contaminating
bacterial protein, the LPS extract was resuspended in 0.5 M
sodium chloride and incubated with a 10-fold greater
volume of ethanol for 2 h at 4C. Following centrifugation
at 8,000 g for 20 min, the supernatant was collected and
lyophilized. To provide characterization, LPS was resus-
pended in sample buﬀer [0.062 M Tris–HCl, pH 6.8, 10%
glycerol, 2% sodium dodecyl sulphate (SDS), 5% 2-mer-
captoethanol, 0.002% Bromophenol blue) and separated by
electrophoresis on 4–15% preformed polyacrylamide gels
within a Phastsystem (GE Healthcare, Giles, UK). Lipo-
polysaccharide was detected based on the silver staining
method of Tsai & Frasch (39), using the PlusOne silver
staining kit (GE Healthcare). Removal of contaminating
proteins was conﬁrmed by staining SDS–polyacrylamide
gels with 0.05% Coomassie Brilliant Blue, 50% methanol,
10% acetic acid for 1 h and destaining with 50% methanol,
10% acetic acid. The absence of nucleic acids was deter-
mined by electrophoresis of samples on 2% agarose gels
containing 50 ng ml)1 of ethidium bromide and using a
Tris-Borate-EDTA (TBE) buﬀer system (Sigma-Aldrich),
followed by visualization under ultraviolet (UV) light using
the BioRad image analysis system (BioRad Laboratories,
Hemel Hempstead, UK).
Cell cytotoxicity assay
Alveolar bone cells, seeded at a density of 1 · 104 cells cm)2
in six-well plates, were cultured in the starting medium
described above, in the presence of 0–1 lg ml)1 of P. gin-
givalis LPS. After 24 h, cells were stained with 0.4% Trypan
blue (Sigma-Aldrich). Blue-staining non-viable cells, and
non-staining viable cells, were immediately counted under
an inverted microscope and the percentage viability was
determined. Assays were performed in triplicate. Cells
incubated in the presence of 0, 100, and 200 ng ml)1 of LPS
demonstrated viability counts of between 95 and 98% and
therefore were used in subsequent analyses to determine the
non-cytotoxic eﬀects of LPS on alveolar bone cells.
Influence of LPS on cell behaviour
Alveolar bone cells were reseeded into six-well plates at
1 · 104 cells cm)2 and cultured with 2 ml of medium, as
described above, supplemented with 0, 100 or 200 ng ml)1
of P. gingivalis LPS. At 1–5 d, 400 ll of medium was re-
moved from triplicate wells at each of the LPS concentra-
tions, replaced with 400 ll of 5 mg ml)1 MTT formazan
(Sigma-Aldrich), and incubated at 37C in a 5% CO2
atmosphere for 4 h, to allow uptake of the dye by viable
cells. The MTT-containing medium was removed and the
cells were washed with PBS and lysed with 1 ml of 0.5 M
dimethylformamide, 20% SDS, at 37C in a 5% CO2
atmosphere for 4 h. The amount of dye released was
quantiﬁed at 570 nm.
Similarly, alveolar bone cells, cultured in six-well plates at
1 · 104 cells cm)2 in 2 ml of medium, supplemented with 0,
100 or 200 ng ml)1 of P. gingivalis LPS, were examined for
membrane-bound alkaline phosphatase activity as a marker
for osteoblast diﬀerentiation. Over 2–28 d, cells from trip-
licate wells at each experimental condition were treated with
0.1% Triton X-100, 50 mM Tris–HCl buﬀer, pH 7.2, for
15 min at 37C. Membrane-released proteins were desalted
using PD-10 columns (GE Healthcare) and alkaline
phosphatase activity was determined by measuring the
hydrolysis of p-nitrophenol using a commercial kit (ALP
Optimized; Sigma-Aldrich). P-values were calculated using
one-way analysis of variance (anova) with the Turkey post-
correction test if the P-value was < 0.05 (Instat Package;
GraphPad Software, San Diego, CA, USA), to determine
the direct diﬀerences in cell numbers and alkaline phos-
phatase activity for LPS-supplemented and unsupplemented
cells, at each time point analysed.
Reverse transcription–polymerase chain reaction
Alveolar bone cells were cultured in six-well plates at
1 · 104 cells cm)2 in 2 ml of medium, supplemented with 0
or 200 ng ml)1 of P. gingivalis LPS, for 28 d. On 2–28 d,
cells were washed twice with PBS and the total cellular
RNA was extracted using a Quiagen RNeasy Mini kit
(Quiagen, Crawley, UK), with contaminating genomic
DNA further eliminated using a DNA-free kit (Ambion,
Warrington, UK). The quantity and purity of RNA was
determined by measuring the absorbance at 260/280 nm,
and cDNA was synthesized from 500 ng of total RNA by
reverse transcription (Promega, Southampton, UK) using
the cycling conditions 25C for 10 min, 42C for 60 min,
and 95C for 5 min. Polymerase chain reactions were
performed using primer sequences to decorin (sense,
5¢-CAATAGCATCACCGTTGTGG-3¢; antisense, 5¢-CCG
GACAGGGTTGCTATAAA-3¢; product size 204 bp),
biglycan (sense, 5¢-CCTCCAGCACCTCTATGCTC-3¢;
antisense, 5¢-ACTTTGAGGATACGGTTGTC-3¢; product
size 262 bp), and glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) (sense, 5¢-TCCCTCAAGATTGTCAGC
AA-3¢; antisense, 5¢-AGATCCACAACGGATACATT-3¢;
product size 307 bp) using the following PCR cycling
parameters: one precycle at 94C for 3 min, followed by 35
cycles at 94C for 1 min, 58C for 1 min, 72C for 1 min, and
one ﬁnal cycle at 72C for 5 min. Reverse transcription–
polymerase chain reaction products were separated by elec-
trophoresis on 2%agarose gels containing ethidiumbromide,
viewed under UV light using the BioRad image analysis
system, and then quantiﬁed using the BioRad Quantity One
calibration programme (BioRad), to determine band inten-
sities by comparison with GAPDH. Band intensities were
measured three times from three separate electrophoretic
separations and means and standard deviations were calcu-
lated to give a semiquantitative analysis and therefore
descriptive, rather than actual, changes in expression levels.
Purification of proteoglycans synthesized by alveolar
bone cells
Alveolar bone cells were reseeded into T-75 ﬂasks at 1 · 104
cells cm)2, supplemented with 0 or 200 ng ml)1 P. gingivalis
LPS, and cultures maintained for 2–28 d, as described
above. Cells were washed twice with PBS and non-collage-
nous proteins were extracted from the synthesized matrix
with 15 ml of 4 M guanidinium chloride, 0.05 M sodium
acetate buﬀer, pH 6.8, containing proteolytic inhibitors
(1 mM iodoacetic acid, 5 mM N-ethylmalemide, 5 mM
benzamidine; Sigma-Aldrich) for 48 h at 4C, with constant
agitation. The guanidinium chloride extracts were exhaus-
tively dialysed, at 4C, against double-distilled water con-
taining proteolytic inhibitors (described above), followed by
dialysis for 1 d against double-distilled water only, and then
lyophilized.
Proteoglycans were puriﬁed from the non-collagenous
extract by anion-exchange chromatography, using a 1-ml
Resource Q column incorporated into a fast protein
Lipopolysaccharide and bone cells 209
liquid chromatography (FPLC) system (GE Healthcare).
Samples were applied to the column in 4 M urea, 50 mM
Tris–HCl, pH 6.8 (5 mg ml)1). Bound proteins were
selectively eluted with a 0–1 M NaCl linear gradient, in
the above buﬀer, over 19 ml. Elution proﬁles at 280 nm
were obtained to identify protein peaks, which were
dialysed against double-distilled water and recovered by
lyophilization prior to reconstitution at 10 mg ml)1 in
double-distilled water. Five microlitres of each of the
recovered protein fractions was blotted onto nitrocellulose
membranes and proteoglycan-rich fractions were identiﬁed
by their immunoreactivity with antibodies LF113 (anti-
decorin) and LF106 (anti-biglycan) (Dr L. Fisher, NIH,
Bethesda, MD, USA) using the 5-bromo-4-chloro-3-ind-
olyphosphate p-toluidine salt (BCIP)/ Nitro Blue tetra-
zolium (NBT) detection system, described below. Core
proteins of the proteoglycans were then obtained for
Western blot analysis by digestion with proteinase-free
chondroitinase ABC (Seikagaku, Tokyo, Japan), as pre-
viously described by Waddington et al. (40).
Western blot analysis
Ten micrograms of core protein samples were dissolved in
30 ll of sample buﬀer (0.062 M Tris–HCl, pH 6.8, 10%
glycerol, 2% SDS, 5% 2-mercapthoethanol, 0.002%
Bromophenol blue). Samples were separated (15 mA, for
3 h, at room temperature) on 4–15% precast gradient SDS-
polyacrylamide gels (BioRad), using a running buﬀer of
25 mM Tris–HCl, 0.2 M glycine, 1% SDS. Separated
components were electroblotted onto polyvinylidene diﬂu-
oride (PVDF) membranes (GE Healthcare) in a Trans-
Blot SD Semi-Dry Electrophoretic Transfer Cell system
(BioRad), for 30 min at 15 V. The membranes were exam-
ined for immunoreactivity with polyclonal antibodies
LF113 (decorin, 1:100) and LF106 (biglycan, 1:100), visu-
alized using secondary goat anti-rabbit immunoglobulin G
(IgG) conjugated to horseradish perioxidase (1:1,000)
(Sigma-Aldrich) and the ECL Plus Western Blotting
Detection Reagent kit (GE Healthcare), with exposure for
30 min onto Hyperﬁlm-ECL (GE Healthcare). Images were
captured using the BioRad Quantity One image-analysis
system (BioRad). As a negative control, to conﬁrm the
absence of non-speciﬁc binding by the antibodies, primary
antibodies LF113 and LF106 were mixed with 100 lg ml)1
of their respective immunizing antigen peptide (courtesy of
Dr L. Fisher) prior to treatment of protein-blotted PVDF
membranes.
Identification of GAG constituents
Glycosaminoglycan chains were released from the puriﬁed
proteoglycan samples (0.5 mg ml)1) with non-speciﬁc pro-
tease type XIV (Sigma-Aldrich) in 0.2 M Tris–HCl, 10 mM
CaCl2, pH 7.5, at 55C, for 18 h, lyophilized, and then
resuspended in double-distilled water equivalent to the
starting volume of the original sample. Two-microlitre
samples were analysed by cellulose acetate electrophoresis
to separate the GAG components, as previously described
by Waddington et al. (40). Glycosaminoglycan compo-
nents were stained with Alcian blue and identiﬁed according
to their electrophoretic mobility in relation to a GAG
standard (Sigma-Aldrich) and their susceptibility to chon-
droitinase ABC and chondroitinase AC (40). Staining
intensities of the GAG components were measured using the
BioRad Quantity One image-analysis system (BioRad
Laboratories) and quantiﬁed by comparison with the com-
mercial standards.
Results
Porphomonas gingivalis LPS characterization
Lipopolysaccharide was extracted from the bacterial cell
walls using a hot phenol–water diﬀerential extraction
method. Electrophoretic separation by sodium dodecyl
sulphate–polyacrylamide gel electrophoresis (SDS-
PAGE), followed by staining with silver nitrate, dem-
onstrated the classical laddering heterogeneous pattern
of LPS (data not shown), which is attributable to the
variability of the O-speciﬁc oligosaccharide moiety (39).
Contaminating DNA and proteins were removed by
precipitation with cetyltrimethylammonium bromide and
ethanol respectively. Staining of SDS-PAGE gels with
Coomassie Brilliant Blue indicated successful removal of
contaminating bacterial proteins for the preparation
from P. gingivalis. Similarly, P. gingivalis LPS contained
minimal nucleic acid content, as assessed by agarose gel
electrophoresis followed by staining of the gel with
ethidium bromide. For comparison, a sample of com-
mercially available Escherichia coli LPS was also exam-
ined by SDS-PAGE and for protein and nucleic acid
content. Of, note E. coli LPS was shown to contain trace
amounts of protein and signiﬁcant amounts of nucleic
acid.
Characterization of alveolar bone cells in culture
During this study optimal culture conditions were
established and cellular activity determined. We found
that it was necessary for alveolar bone cells to be cul-
tured ﬁrst in the absence of mineral-inducing factors.
Cell numbers rose sharply over the ﬁrst 5 d post-resee-
ding, after which viable cell numbers remained constant
(demonstrated in Fig. 1A, no-LPS control). Following
cessation of the proliferative stage, mineral-inducing
factors (10 mM b-glycerophosphate, 10)8 M dexameth-
asone, and 50 lg ml)1 of ascorbic acid) were added and
the cultures were maintained for up to 28 d. Alkaline
phosphatase activity was also seen to rise during this
period (Fig. 1B, no-LPS control). Over the period of
culture (1–28 d), cells were examined, using immuno-
histochemical techniques, for the appearance of a range
of bone protein markers that assisted in deﬁning the start
of matrix deposition and conﬁrmed the synthesis of
bone-related proteins. von Kossa staining was used to
demonstrate the deposition of calcium phosphate min-
eral salts. For brevity, the results are not shown but
described. In order to produce mineralizing nodules,
bone cells required a high-calcium environment to pro-
mote mineral deposition. Nodules that stained positive
for calcium phosphate mineral deposition, as determined
using the von Kossa stain, appeared from 17 d post-
reseeding. As control studies, dermal ﬁbroblasts were
grown in the same high-calcium medium and the lack of
mineral deposition around these cells conﬁrmed that
mineral formation in the alveolar bone cultures was not a
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result of spontaneous calcium phosphate precipitation.
Immunohistochemical staining of the extracellular ma-
trix demonstrated the presence of collagen type I (from
around 7 d post-reseeding), osteopontin (from 10 d),
osteonectin (13 d), and bone sialoprotein and osteocalcin
(from 17 d). These results thus deﬁned a cell prolifera-
tion period over the ﬁrst 5 d of culture, with osteoid
production commencing around 7 d, where collagen
synthesis was evident. Calcium phosphate mineral
deposition, as evidenced by the detection of bone sialo-
protein, osteocalcin and von Kossa staining, was pre-
sumed to be established by 17 d. These formed the
justiﬁcation for the analysis of these days throughout the
remainder of the study.
Effect of P. gingivalis LPS on cellular behaviour
The inﬂuence of P. gingivalis LPS on alveolar bone cell
numbers, as measured by MTT formazan uptake by
viable cells, is shown in Fig. 1A. When compared with
cells cultured in the absence of LPS, the presence of 100
or 200 ng ml)1 of P. gingivalis LPS produced a signiﬁ-
cant, concentration-dependent increase (P < 0.05) in
cell proliferation over the ﬁrst 5 d postreseeding. This
eﬀect was more pronounced at the initial stages of cul-
ture, where cell numbers in the presence of 100 and
200 ng ml)1 of P. gingivalis LPS were increased by 47%
and 102% respectively at 1 d (P < 0.001). By 5 d, the
eﬀect of P. gingivalis LPS appeared to be reduced, with
cell numbers showing only a 7.4% increase at
100 ng ml)1 and an 11.1% increase at 200 ng ml)1
(P < 0.05). Figure 1B demonstrates the eﬀect of
P. gingivalis LPS on membrane-bound alkaline phos-
phatase activity. Alkaline phosphatase activity was sig-
niﬁcantly inhibited in cells incubated with P. gingivalis
LPS, particularly from 10 d onwards (P < 0.001).
Again, the observed eﬀect was concentration dependent,
with activity at 28 d for cells cultured in the presence of
100 ng ml)1 of LPS decreasing by 42% compared with a
decrease of 56% in cells cultured in the presence of
200 ng ml)1 of LPS.
Influence of P. gingivalis LPS on biglycan and decorin
mRNA levels
All subsequent studies investigating the eﬀect of LPS on
proteoglycan expression utilized bone cells supplemented
with 200 ng ml)1 of P. gingivalis LPS, where eﬀects on
cell numbers and alkaline phosphatase were most
marked, without being lethal to the cells. Reverse tran-
scription–polymerase chain reaction (RT-PCR) analysis
demonstrated diﬀerential gene expression in the presence
and absence of LPS, as shown in Fig. 2. Densitometric
analysis of the RT-PCR products obtained for biglycan
and decorin, and normalization against GAPDH levels,
gave a semiquantitative analysis. While this method of
quantiﬁcation does not provide a highly accurate value,
it does allow us to identify trends and gross changes in
the expression patterns observed in the presence and
absence of LPS. In the absence of LPS, high expression
of biglycan mRNA was observed at 2 d, which corre-
sponded to a rapid proliferation in cell number
(Fig. 2A). In the presence of LPS, biglycan mRNA was
considerably reduced. At 5 and 10 d, a period that our
characterization studies suggested was associated with
the early deposition of a collagenous matrix within the
culture (described above), biglycan mRNA expression
was negligible in the absence of LPS, but substantial
levels were observed in the presence of LPS. On 17, 20,
and 28 d, when our characterization studies indicated
expression of bone-diﬀerentiation proteins and the for-
mation of calcium phosphate mineral-containing nod-
ules, high levels of biglycan mRNA expression appeared
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Fig. 1. The inﬂuence of non-lethal levels of lipopolysaccharide
(LPS) on cell behaviour during cell culture. Alveolar osteoblast-
like cells were seeded at 1 · 104 cells cm)2 and cultured in the
presence of ( ) 0 ng ml)1 P. gingivalis LPS, ( ) 100 ng ml)1
P. gingivalis LPS, or ( ) 200 ng ml)1 P. gingivalis LPS. (A) Cell
numbers were determined for 1–5 d by measuring the uptake by
viable cells of the chromagenic substrate, MTT. Viable cell
numbers increased in the presence of LPS, compared with the
non-supplemented control. This was statistically signiﬁcant
(**P < 0.001) at 1 d for cells in the presence of 100 and
200 ng ml)1 of LPS and statistically signiﬁcant (*P < 0.05) at
days 2–5 for cells cultured in the presence of 200 ng ml)1 of
LPS. (B) Alkaline phosphatase activity was assessed for cells in
culture for 2–28 d. Alkaline phosphatase was released from the
cell membrane by treatment with the detergent Triton X-100
and quantiﬁed as a measure of p-nitrophenol hydrolysis. For
cells cultured in the presence of 200 ng ml)1 of LPS, alkaline
phosphatase was signiﬁcantly reduced compared with the non-
supplemented control (*P < 0.05 and **P < 0.001). Alkaline
phosphatase activity was also reduced in the presence of
100 ng ml)1 of LPS, although this was not statistically signiﬁ-
cant at 2 and 5 d, but highly signiﬁcant at 10–28 d
(**P < 0.001).
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to be resumed in the absence of LPS. However, the levels
of expression were reduced in the presence of LPS at 17,
20, and 28 d.
Expression of decorin mRNA by cells in the absence of
P. gingivalis LPS rose steadily at 2, 5, and 10 d, fell
slightly at 17 d and then rose again during the formation
of mineralizing nodules from 20 d onwards (Fig. 2B).
For bone cells grown in the presence of LPS, small, and
possibly debatable, changes in decorin mRNA levels
were apparent on 2, 5, 17, and 20 d. However, in the
presence of LPS, large reductions in the expression of
decorin mRNA were observed at 10 d (associated with
the synthesis of a collagen matrix) and 28 d (associated
with mineral nodule formation).
Influence of P. gingivalis LPS on synthesis and
extracellular processing of biglycan and decorin
Proteoglycans were extracted from the extracellular ma-
trix synthesized by the cells in the presence and absence of
LPS. For each time-point examined, proteins were frac-
tionated by anion-exchange chromatography and a pro-
teoglycan-rich fraction was identiﬁed eluting at a salt
concentration of 0.6–0.75 M NaCl from a Resource Q
column, typical of our previously published elution pro-
ﬁles isolating proteoglycan from mineralized tissues (15).
Western blot immunocharacterization of biglycan and
decorin, and their respective processed fragments, isolated
from the extracellular matrix surrounding cells incubated
in the presence or absence ofP. gingivalisLPS, is shown in
Fig. 3. Immunoreactivity for biglycan was detected on
day 2 for cells cultured in the absence ofP. gingivalis LPS,
with bands of approximately 62 and 49 kDa evident.
Protein levels appeared to decrease during matrix matu-
ration (5 and 10 d), with a notable loss of the 49 kDa
band. These bands re-appeared during mineral deposition
at 17, 20, and 28 d, with an additional band evident at
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Fig. 2. Semiquantitative reverse transcription–polymerase
chain reaction (RT-PCR) analysis showing the eﬀect of Por-
phyromonas gingivalis lipopolysaccharide (LPS) on the mRNA
levels of (A) biglycan and (B) decorin. Alveolar bone cells were
seeded at 1 · 104 cells percm2 and cultured in the presence of
( ) 0 ng ml)1or ( ) 200 ng ml)1 of P. gingivalis–LPS, for 2–
28 d. mRNA was isolated and the levels were determined by
reverse transcription over 35 polymerase chain reaction (PCR)
cycles, using the appropriate primers. Polymerase chain reac-
tion products were separated on agarose gels, examples of
which are shown. The experiments were performed in duplicate
and repeated on three separate occasions. Gel images were
examined by densitometric analysis and the volume densities of
the ampliﬁed products were normalized against glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) control values. Mean
and standard deviation from triplicate samples were calculated
to observe trends in the data. Lipopolysaccharide (LPS) was
observed to have a major eﬀect on the pattern of mRNA
expression for both biglycan and decorin.
Fig. 3. Eﬀect of Porphyromonas gingivalis lipopolysaccharide
(LPS) on extracellular synthesis and remodelling of biglycan
and decorin present within the extracellular matrix synthesized
and remodelled by the alveolar bone cells. Cells were seeded at
1 · 104 cells per cm2, in the presence of 0 or 200 ng ml)1 of
P. gingivalis LPS and maintained in culture for 2–28 d. Prote-
oglycans were extracted from the synthesized matrix by treat-
ment with 4 M guanidinium chloride and then puriﬁed by
anion-exchange chromatography. The proteoglycan-rich frac-
tions were examined by western blot analysis using polyclonal
antibodies LF106 (anti-biglycan) and LF113 (anti-decorin).
Clear diﬀerences in the protein levels of biglycan and metabolic
products extractable from the matrix were evident in the pres-
ence (+) and absence ()) of LPS. Diﬀerence in the higher
molecular weight decorin protein bands were evident on com-
paring protein expression into the matrix in the presence and
absence of LPS, indicating changes in the extracellular pro-
cessing of this proteoglycan in the matrix. Experiments were
performed in duplicate on three separate occasions. A typical
western blot image is shown.
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approximately 98 kDa. In the presence of P. gingivalis
LPS, the appearance of biglycan in thematrix appeared to
be delayed, with protein levels notably reduced at 2 and
5 d, which then appreciably increased at 10 d. During
phases when calcium phosphate mineral deposition was
expected, biglycan protein levels were greatly reduced
once more.
In the absence of LPS, immunodetection for decorin
produced a visible immunoresponse after 5 d, by cells
cultured in the absence of LPS. On day 5 a faint single
band at 28 kDa was apparent, which probably represents
a degradation product because the calculated molecular
weight of the decorin core protein is approximately
49 kDa (14). Faint decorin bands of 28 and 78 kDa were
also evident on day 10. In the presence ofP. gingivalisLPS
on day 5, there was a small increase in detectable decorin
core protein. At day 10, the higher-molecular-weight band
was undetectable, although the 28 kDa band was still
apparent, suggesting alteration in the extracellular prote-
olytic processing of this proteoglycan. In the absence of
P. ginigvalis LPS, decorin stained much more strongly at
17, 20, and 28 d, with bands evident at approximately 78,
62, 49, 42, 38, and 28 kDa. In the presence of P. gingivalis
LPS, there was a notable reduction in the intensity of the
78- and 62-kDa decorin bands on days 17 and 20, again
suggesting altered extracellular proteolytic processing.No
diﬀerence was apparent for the level of decorin at 28 d. As
a negative control, the immunizing peptide sequence for
biglycan or decorin was premixed with the corresponding
polyclonal antibody, prior to incubation with the blotted
PDVF membranes. For both antibodies, immunoreac-
tivity with the blotted proteins was completely lost, indi-
cating that no non-speciﬁc binding of the antibody with
proteins other than biglycan and decorin had occurred
(data not shown).
The effects of P. gingivalis LPS on GAG constituents
Examples showing the separation (by cellulose acetate
electrophoresis) of the constituent GAGs, conjugated to
the proteoglycan core proteins and synthesized in the
presence and absence of LPS, are shown in Fig. 4. Gly-
cosaminoglycans were identiﬁed by their electrophoretic
mobility and by their susceptibility to chondroitinases.
The faster migrating band was susceptible to both
chondroitinases AC and ABC, identifying this material
as CS. The medium migrating band was susceptible to
chondroitinase ABC digestion only, thus conﬁrming the
identity of this band as DS. The slowest migrating band
was identiﬁed as hyaluronan, but its presence may be
attributable to serum added to the culture medium and
not necessarily derived from the alveolar bone cells.
Hence, the levels of GAGs, calculated from the volume
densities of the Alcian blue-stained bands, were
expressed as percentages of DS and CS (Fig. 4). For
alveolar bone cells cultured in the absence of P. gingivalis
LPS during phases associated with cell growth (2 and
5 d), both DS and CS were detected, with higher levels of
DS present (DS: 70% at 2 d; 62% at 5 d), compared with
CS. During the matrix-formation phase (10 d), DS rep-
resented 53% of the sulfated GAG. Following exposure
to P. gingivalis LPS, during culture periods associated
with cell proliferation and matrix formation, the per-
centage ratio of DS to CS was noticeably increased
compared with the no-LPS control. During the miner-
alization phase (17–28 d), CS was the only sulfated GAG
detected when alveolar bone cells were cultured in the
absence of LPS. However, in the presence of the LPS, DS
was still apparent within the matrix during periods where
mineral deposition was expected.
Discussion
Pathogenic agents that hamper the ability of the host
tissue cells to initiate bone repair during periodontal
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Fig. 4. Percentage distribution of sulfated glycosaminoglycan
(GAG) conjugated to proteoglycans, synthesized by the alveo-
lar bone cells, cultured in the presence of (A) 0 and (B)
200 ng ml)1 P. gingivalis lipopolysaccharide (LPS) for 2–28 d.
Proteoglycans were isolated from the synthesized matrices by
4 M guanidinium chloride and anion-exchange chromatogra-
phy. Experiments were performed in duplicate on three separate
occasions. GAGs were released from protein cores by protease
digestion, separated by cellulose acetate electrophoresis, and
visualized by Alcian blue staining. GAGs were semiquantiﬁed
by densitometric analysis, where volume densities were com-
pared with GAG standards applied at a known concentration.
Chondroitin sulfate (CS) ( ) and dermatan sulfate (DS) ( )
were both identiﬁed within the early stages of culture. In the
presence of LPS, DS continued to persist within the cellular
matrix up to 28 d. Inserts show examples obtained for the
separation of GAG associated with bone cultures at 10 and
20 d. C4S, chondroitin 4-sulphate; C6S, chondroitin 6-sulphate;
HA, hyaluronan; HS, heparin sulphate; Std, standard.
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disease are important considerations in continued disease
progression. Bone repair may be viewed as a series of
distinct, but overlapping, stages that can be recapitulated
in vitro. The inﬂuence of P. gingivalis LPS on the alve-
olar bone cells is thus considered in terms of develop-
mental stages related to cell proliferation, osteoid
production (coinciding with collagen synthesis), and
mineral deposition (coinciding with bone sialoprotein,
osteocalcin synthesis, and detection of calcium phos-
phate mineral by von Kossa staining).
Our results demonstrated that P. gingivalis LPS
enhanced the proliferation of alveolar bone cells, but
appeared to impede the formation of the osteoblast
phenotype, as evidenced by reduced alkaline phospha-
tase activity. These results contribute to other related,
albeit conﬂicting, published ﬁndings. A similar decrease
in alkaline phosphatase activity has been demonstrated
using rat calvarial cells cultured in the presence of
P. gingivalis LPS (33, 41), Prevotella intermedia LPS (42)
or sonicated extracts of P. gingivalis (5). These studies
also demonstrated a concomitant decrease in mineral
deposition, as established by reduced bone nodule
formation and reduced incorporation of calcium or
phosphate.
These results do contradict the results of studies pub-
lished previously. For instance, sonicated extracts of
P. gingivalis had no eﬀect on the alkaline phosphatase
activity of MC3T3-E1, a pre-osteoblast-like cell line (43);
and P. gingivalis LPS had no eﬀect on the cell number
(as determined by DNA content) of cultures derived
from the periosteum of calvarial bone (33). These con-
tradictions may reﬂect diﬀerent biological responses
relative to the source and progenitor status of the cells
analysed. The cells analysed from alveolar bone chips
derive from progenitor cells from periodontal ligament
lining the bone surface (including Sharpeys ﬁbres), or
marrow cavities exposed as a consequence of preparing
small bone chips. The cell model system used in the
present study is thus highly relevant for understanding
periodontal disease because these progenitor populations
represent the two main sources of cells recruited during
attempts at periodontal tissue repair. Of note, studies
characterizing stem/progenitor cell populations of dental
tissues have suggested that the periodontal ligament
contains a unique population of postnatal stem cells
distinct from bone marrow (36). Furthermore, P. gingi-
valis LPS has been shown to stimulate cell proliferation
in human periodontal ligament cells (44). The source and
preparation of the pathogenic agent should also be
considered in regard to the diversity of the published
ﬁndings. Diﬀerent cellular responses regarding the
alkaline phosphatase activity of MC3T3-E1 cells have
been reported for sonicated extracts of P. gingivalis,
P. intermedia, and Aggregatibacter (Actinobacillus)
actinomycetemcomitans (43). Likewise, P. intermedia and
A. actinomycetemcomitans produce diﬀerent apoptopic
responses on osteoblast-like cell lines, including MG63
(45). The structure of LPS traditionally consists of three
main domains and chemical diﬀerences in the residue
composition of the inner oligosaccharide core and of the
length and phosphorylation of the lipid A component
have been identiﬁed to exist on comparison of the LPS
from all these periodontal pathogens with that of E. coli
(46). Such diﬀerences have been suggested to be
responsible for the diﬀerences in the endotoxic potential
observed for these diﬀerent pathogens (46). Diﬀerential
cellular eﬀects were obtained when comparing sonicated
bacterial extracts with puriﬁed LPS. Our study exten-
sively puriﬁed LPS, conﬁrming the removal of protein
and DNA that are present in commercial sources of LPS
from E. coli and have the potential to exhibit an eﬀect on
cellular activity.
A major focus of the present study was the inﬂuence of
P. gingivalis LPS on the synthesis of biglycan and
decorin (which have roles in cellular signalling, matrix
formation, and mineralization) within the matrix (18).
During periods within the culture associated with cell
proliferation (1–5 d), mRNA and protein expression of
biglycan was initially high and then fell, prior to collagen
deposition. In the presence of P. gingivalis LPS, biglycan
expression appeared to be delayed, absent on day 2, high
on day 5, and continuing to day 10. The expression of
biglycan during early osteogenesis is a major consider-
ation in the bone repair process because it is increasingly
recognized to provide a role in regulating cell activity.
Calvarial-derived osteoblasts from biglycan-deﬁcient
mice have reduced the diﬀerentiation capability and
reduced the responsiveness to BMP-4 (47). Biglycan has
also been described as a positive modulator of BMP-2
osteoblast diﬀerentiation (48) and has an ability to bind
growth factors, including TGF-b and TNF-a (23–25),
sequestering such molecules to the matrix and thus
indirectly inﬂuencing cellular activity.
Within our culture system of alveolar bone cells, col-
lagen deposition was ﬁrst observed around day 7.
Decorin, but not biglycan, has been shown to bind to
collagen and inﬂuence collagen ﬁbril formation (19, 20,
22), which ultimately provides the provisional matrix for
mineral deposition. In the presence of P. gingivalis LPS,
this study reported increased levels of decorin on day 5,
just prior to collagen synthesis. However, on day 10,
when collagen ﬁbril formation was expected, decorin
levels were reduced compared with the no-LPS control.
In addition, extracellular proteolytic processing of de-
corin at this time point appeared to be altered, with the
loss of the higher-molecular-weight decorin band. The
altered decorin expression would ultimately inﬂuence
collagen ﬁbril assembly, producing a matrix inadequate
for proper mineralization. Studies have shown that
DS-substituted decorin, isolated from soft connective
tissues, retards the rate of collagen ﬁbrillogenesis (19,
20). Conversely, CS-substituted decorin, isolated from
cartilage or produced through recombinant techniques,
appeared to promote collagen ﬁbrillogenesis (19, 20, 22).
In the presence of P. gingivalis LPS, DS-substituted
proteoglycan persisted within the matrix, which would
present an additional eﬀect on collagen ﬁbrillogenesis
during osteoid formation.
Whilst not quantiﬁably established in this study, other
studies have demonstrated that LPS aﬀects mineral
deposition by bone cells in vitro (5, 33). Both decorin and
biglycan have been proposed to have roles in regulating
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the deposition of mineral in bone. Pertinent to this
study, in vitro studies have shown that the inclusion of
DS–biglycan or CS–bone proteoglycans into a gelatin
matrix, saturated in calcium and phosphate ions, pro-
moted hydroxyapatite deposition, but mineral deposi-
tion was inhibited in gels containing DS–decorin (26).
The continued presence of DS-substituted decorin (or a
process product) in the matrix of alveolar bone cells
cultured in the presence of P. gingivalis LPS would
therefore have a further inhibitory eﬀect on the forma-
tion of mineralized bone nodules. In addition, the pres-
ent study demonstrated reduced biglycan levels at time
points associated with mineral deposition. Biglycan is a
proteoglycan which Boskey and co-workers suggested
played a more signiﬁcant role in the regulation of min-
eralization than decorin (26).
To conclude, this study has identiﬁed that P. gingivalis
LPS is capable of increasing the proliferation of pro-
genitor cell populations derived from alveolar bone,
delaying their subsequent diﬀerentiation (as judged by
reduced alkaline phosphatase activity and altered
expression of decorin and biglycan) with potential inﬂu-
ences on alveolar bone cell activity and matrix formation.
The inﬂuence of LPS on the synthesis of matrix proteins,
such as biglycan and decorin, therefore presents one,
albeit signiﬁcant, consequence of the pathogenic action of
P. gingivalis in the progression of periodontal disease.
Raised levels of decorin and biglycan in the gingival
crevicular ﬂuid (GCF) have been proposed as potential
markers of alveolar bone destruction, during periodontal
disease and peri-implantitis (49, 50). The knowledge that
the expression of decorin and biglycan by alveolar bone
cells, derived from periodontal ligament and bone mar-
row sources, is reduced in the presence of LPS, conﬁrms
that the decorin and biglycan observed in the GCF during
these clinical situations derives from the degradation of
the matrix, rather than from attempts of the tissue to
undergo repair.
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